Renoprotective effect of azelnidipine in rats

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 12, 2008, Pages 2237-2244

  Kurashige, Tomomi ^a   Abe, Katsushige ^a   Furusu, Akira ^a   Miyazaki, Masanobu ^a   Obata, Yoko ^a   Xia, Zihyin ^a   Nakazawa, Masayuki ^a   Nakazawa, Yuka ^a   Funakoshi, Satoshi ^b   Harada, Takashi ^a   Koji, Takehiko ^c   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sakuramachi Clinic   (Japan)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Antioxidant; Azelnidipine; Calcium channel blocker; Hypertension; Renoprotective effect

Indexed keywords

4 HYDROXYNONENAL; AZELNIDIPINE; CHOLESTEROL; COLLAGEN TYPE 3; CREATININE; HEAT SHOCK PROTEIN 47; HYDRALAZINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; OLMESARTAN; PROTEIN P22; PROTEIN P47; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; FIBROSING ALVEOLITIS; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; MALE; NONHUMAN; RAT; RENAL PROTECTION; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AZETIDINECARBOXYLIC ACID; BLOOD PRESSURE; BLOOD UREA NITROGEN; CALCIUM CHANNEL BLOCKERS; COLLAGEN TYPE III; DATA INTERPRETATION, STATISTICAL; DIHYDROPYRIDINES; HSP47 HEAT-SHOCK PROTEINS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MACROPHAGES; MALE; NADPH OXIDASE; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, INBRED SHR;

EID: 57349119202     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.2237     Document Type: Article

References (32)

1. Kobori H., Ozawa Y., Suzaki Y., Nishiyama A., J. Am. Soc. Nephrol., 16, 2073-2080 (2005).
2. Fujiwara Y., Kitamura E., Ueda N., Fukunaga M., Orita Y., Kamada T., Kidney Int., 36, 985-991 (1989).
3. Orth S. R., Nobiling R., Bönisch S., Ritz E., Kidney Int., 49, 868-879 (1996).
4. Sluiter H. E., Wetzels J. F. M., Huysmans F. T. M., Koene R. A. P., J. Cardiovasc. Pharmacol., 10, S154-S161 (1987).
5. Yagil Y., Miyamoto M., Frasier L., Oizumi K., Koike H., Am. J. Hypertens., 7, 637-646 (1994).
6. Arendshorst W. J., Brannstrom K., Ruan X., J. Am. Soc. Nephrol., 10, S149-S161 (1999).
7. Carmines P. K., Navar L. G., Am. J. Physiol., 256, F1015-F1020 (1999).
8. Iversen B. M., Arendshorst W. J., J. Am. Soc. Nephrol., 10, S84-S89 (1999).
9. Kondo N., Kiyomoto H., Yamamoto T., Miyake A., Sun G. P., Rahman M., Hitomi H., Moriwaki K., Hara T., Kimura S., Abe Y., Kohno M., Nishiyama A., J. Pharmacol. Exp. Ther., 316, 1047-1052 (2006).
10. Nakano K., Egashira K., Ohtani K., Gang Z., Iwata E., Miyagawa M., Sunagawa K., Atherosclerosis, 196, 172-179 (2008).
11. Okamoto K., Yamori Y., Nagaoka A., Circ. Res., 34, 143-153 (1974).
12. Kim S., Ohta K., Hamaguchi A., Omura T., Yukimura T., Miura K., Inada Y., Wada T., Ishimura Y., Chatani F., Kidney Int., 46, 1346-1358 (1994).
13. Oizumi K., Miyamoto M., Koike H., Biol. Pharm. Bull., 17, 407-410 (1994).
14. Izuhara Y., Nangaku M., Inagi R., Tominaga N., Aizawa T., Kurokawa K., van Ypserle de Strihou C., Miyata T., J. Am. Soc. Nephrol., 16, 3631-3641 (2005).
15. Pugsley M. K., Proc. West. Pharmacol. Soc., 48, 35-38 (2005).
16. Sawamura I., Hazama F., Kinoshita M., Jpn. Circ. J., 54, 1274-1282 (1990).
17. Irzyniec T., Mall G., Greber D., Ritz E., Am. J. Hypertens., 5, 437-443 (1992).
18. Yamori Y., Horie R., Handa H., Sato M., Fukase M., Stroke, 7, 46-53 (1976).
19. Kim S., Tokuyama M., Hosoi M., Yamamoto K., Hypertension, 20, 280-291 (1992).
20. Wang X., Desai K., Juurlink B. H. J., de Champlain J., Wu L., Kidney Int., 69, 281-287 (2006).
21. Umemoto S., Tanaka M., Kawahara S., Kubo M., Umeji K., Hashimoto R., Matsuzaki M., Hypertens. Res., 27, 877-885 (2004).
22. Rodriguez-Iturbe B., Zhan C. D., Quiroz Y., Sindhu R. K., Vaziri N. D., Hypertension, 41, 341-346 (2003).
23. Ivanovski O., Szumilak D., Nguyen-Khoa T., Ruellan N., Phan O., Lacour B., Descamps-Latscha B., Drüeke T. B., Massy Z. A., Kidney Int., 67, 2288-2294 (2005).
24. Kang S. K., Rabbani Z. N., Folz R. J., Golson M. L., Huang H., Yu D., Samulski T. S., Dewhirst M. W., Anscher M. S., Vujaskovic Z., Int. J. Radiat. Oncol. Biol. Phys., 57, 1056-1066 (2003).
25. Shaw T. R., Turnbull C. M., Sutherland G. R., Campanella C., Kerr F., Burton J. B., Am. Heart J., 129, 394-399 (1995).
26. Edelstein C. L., Yaqoob M. M., Alkhunaizi A. M., Gengaro P. E., Nemenoff R. A., Wang K. K., Schrier R. W., Kidney Int., 50, 1150-1157 (1996).
27. Traylor L. A., Mayeux P. R., Nitric Oxide, 1, 432-438 (1997).
28. Satoh S., Yamaguchi T., Hitomi A., Sato N., Shiraiwa K., Ikegaki I., Asano T., Shimokawa H., Eur. J. Pharmacol., 455, 169-174 (2002).
29. Takemori K., Ishida H., Dote K., Yamamoto K., Ito H., Can. J. Physiol. Pharmacol., 83, 785-790 (2005).
30. Yamagishi S., Inagaki Y., Nakamura K., Imaizumi T., J. Cardiovasc. Pharmacol., 43, 724-730 (2004).
31. Naito Y., Shimozawa M., Manabe H., Nakabe N., Katada K., Kokura S., Yoshida N., Ichikawa H., Kon T., Yoshikawa T., Eur. J. Pharmacol., 546, 11-18 (2006).
32. Takahashi K., Shimokado K., Yoshida M., Eur. J. Pharmacol., 552, 162-169 (2006).